ALK and cholangiocarcinoma: Additionally, rarer genetic alterations, including NTRK1/2/3, ROS1, ALK fusions, BRAF mutations, and microsatellite instability−high (MSI-H)/mismatch repair deficiency (dMMR), have also been reported in CCA.4, 18, 19